These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 14767572)

  • 41. Promoter hypermethylation profile of kidney cancer.
    Dulaimi E; Ibanez de Caceres I; Uzzo RG; Al-Saleem T; Greenberg RE; Polascik TJ; Babb JS; Grizzle WE; Cairns P
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):3972-9. PubMed ID: 15217927
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aberrant methylation of the CHFR gene is frequently detected in non-invasive colorectal cancer.
    Morioka Y; Hibi K; Sakai M; Koike M; Fujiwara M; Kodera Y; Ito K; Nakao A
    Anticancer Res; 2006; 26(6B):4267-70. PubMed ID: 17201143
    [TBL] [Abstract][Full Text] [Related]  

  • 43. p16 Gene methylation in colorectal tumors: correlation with clinicopathological features and prognostic value.
    Sanz-Casla MT; Maestro ML; Vidaurreta M; Maestro C; Arroyo M; Cerdán J
    Dig Dis; 2005; 23(2):151-5. PubMed ID: 16352895
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quantitative validation of GJC1 promoter hypermethylation in benign and malignant colorectal tumors.
    Ahmed D; Lothe RA; Rivedal E; Lind GE
    Endocr Relat Cancer; 2011 Oct; 18(6):C31-4. PubMed ID: 21868474
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunoprecipitation of nucleosomal DNA is a novel procedure to improve the sensitivity of serum screening for the p16 hypermethylation associated with colon cancer.
    Sakamoto J; Fujiya M; Okamoto K; Nata T; Inaba Y; Moriichi K; Tanabe H; Mizukami Y; Watari J; Ashida T; Kohgo Y
    Cancer Epidemiol; 2010 Apr; 34(2):194-9. PubMed ID: 20129840
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Decreased expression of repulsive guidance molecule member A by DNA methylation in colorectal cancer is related to tumor progression.
    Zhao ZW; Lian WJ; Chen GQ; Zhou HY; Wang GM; Cao X; Yang HJ; Hou YP
    Oncol Rep; 2012 May; 27(5):1653-9. PubMed ID: 22367090
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The potential prognostic, predictive, and therapeutic values of DNA methylation in cancer. Commentary re: J. Kwong et al., Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma. Clin. Cancer Res., 8: 131-137, 2002, and H-Z. Zou et al., Detection of aberrant p16 methylation in the serum of colorectal cancer patients. Clin. Cancer Res., 8: 188-191, 2002.
    Widschwendter M; Jones PA
    Clin Cancer Res; 2002 Jan; 8(1):17-21. PubMed ID: 11801535
    [No Abstract]   [Full Text] [Related]  

  • 48. Methylation of OSMR gene is frequently observed in non-invasive colorectal cancer.
    Hibi K; Goto T; Sakuraba K; Shirahata A; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y
    Anticancer Res; 2011 Apr; 31(4):1293-5. PubMed ID: 21508378
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Screening the differentially methylated DNA sequences of colorectal cancer by methylated CpG islands amplification coupled with representational difference analysis].
    Zhu YM; Lin J; Huang Q; Lai MD
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Oct; 20(5):425-9. PubMed ID: 14556198
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Methylation of the homeobox gene, HOPX, is frequently detected in poorly differentiated colorectal cancer.
    Harada Y; Kijima K; Shinmura K; Sakata M; Sakuraba K; Yokomizo K; Kitamura Y; Shirahata A; Goto T; Mizukami H; Saito M; Kigawa G; Nemoto H; Hibi K
    Anticancer Res; 2011 Sep; 31(9):2889-92. PubMed ID: 21868534
    [TBL] [Abstract][Full Text] [Related]  

  • 51. DNA methylation in serum and tumors of cervical cancer patients.
    Widschwendter A; Müller HM; Fiegl H; Ivarsson L; Wiedemair A; Müller-Holzner E; Goebel G; Marth C; Widschwendter M
    Clin Cancer Res; 2004 Jan; 10(2):565-71. PubMed ID: 14760078
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Methylation status of normal background mucosa is correlated with occurrence and development of neoplasia in the distal colon.
    Hiraoka S; Kato J; Horii J; Saito S; Harada K; Fujita H; Kuriyama M; Takemoto K; Uraoka T; Yamamoto K
    Hum Pathol; 2010 Jan; 41(1):38-47. PubMed ID: 19733896
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fibulin-1 is downregulated through promoter hypermethylation in colorectal cancer: a CONSORT study.
    Xu Z; Chen H; Liu D; Huo J
    Medicine (Baltimore); 2015 Apr; 94(13):e663. PubMed ID: 25837757
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detection of vimentin (VIM) methylation in the serum of colorectal cancer patients.
    Shirahata A; Sakuraba K; Goto T; Saito M; Ishibashi K; Kigawa G; Nemoto H; Hibi K
    Anticancer Res; 2010 Dec; 30(12):5015-8. PubMed ID: 21187483
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evidence that DNA methylation imbalance is not involved in the development of malignant mesothelioma.
    Bagwe AN; Kay PH; Spagnolo DV
    Anticancer Res; 1997; 17(5A):3341-3. PubMed ID: 9413169
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epigenetic Alteration by DNA Methylation of ESR1, MYOD1 and hTERT Gene Promoters is Useful for Prediction of Response in Patients of Locally Advanced Invasive Cervical Carcinoma Treated by Chemoradiation.
    Sood S; Patel FD; Ghosh S; Arora A; Dhaliwal LK; Srinivasan R
    Clin Oncol (R Coll Radiol); 2015 Dec; 27(12):720-7. PubMed ID: 26344356
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Methylation of CDX2 as a Predictor in Poor Clinical Outcome of Patients with Colorectal Cancer.
    Jiang G; Luo C; Sun M; Zhao Z; Li W; Chen K; Fan T
    Genet Test Mol Biomarkers; 2016 Nov; 20(11):710-714. PubMed ID: 27754705
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Methylation alterations of the MyoD1 upstream region are predictive of subclassification of human rhabdomyosarcomas.
    Chen B; Dias P; Jenkins JJ; Savell VH; Parham DM
    Am J Pathol; 1998 Apr; 152(4):1071-9. PubMed ID: 9546368
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Methylation of TFPI2 no longer detected in the serum DNA of colorectal cancer patients after curative surgery.
    Hibi K; Goto T; Shirahata A; Saito M; Kigawa G; Nemoto H; Sanada Y
    Anticancer Res; 2012 Mar; 32(3):787-90. PubMed ID: 22399594
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MYOD-1 in normal colonic mucosa--role as a putative biomarker?
    Arasaradnam RP; Quraishi MN; Commane D; Mathers JC; Bradburn M
    BMC Res Notes; 2012 Jul; 5():240. PubMed ID: 22591756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.